Substrate recognition by the 4‐hydroxytryptamine kinase PsiK in psilocybin biosynthesis

Kai Rogge,Tobias Johannes Wagner,Dirk Hoffmeister,Bernhard Rupp,Sebastiaan Werten
DOI: https://doi.org/10.1002/1873-3468.15042
2024-10-26
FEBS Letters
Abstract:X‐ray crystallography and structure‐guided mutagenesis were used to gain insight into substrate recognition by the kinase that enables biosynthesis of psilocybin, the hallucinogenic substance in Psilocybe (magic) mushrooms. The results of this work will support bioengineering efforts aimed at generating novel variants of psilocybin with improved therapeutic properties. Psilocybin, the natural hallucinogen from Psilocybe (magic) mushrooms, is a highly promising drug candidate for the treatment of depression and several other mental health conditions. Biosynthesis of psilocybin from the amino acid l‐tryptophan involves four strictly sequential modifications. The third of these, ATP‐dependent phosphorylation of the intermediate 4‐hydroxytryptamine, is catalysed by PsiK. Here we present a crystallographic analysis and a structure‐based mutagenesis study of this kinase, providing insight into its mode of substrate recognition. The results of our work will support future bioengineering efforts aimed at generating variants of psilocybin with enhanced therapeutic properties.
cell biology,biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?